World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhao QY, Wei SJ. Exosomal miR-191 promotes colorectal cancer progression by inducing M2 macrophage polarization and inhibiting ferroptosis. World J Gastrointest Oncol 2025; 17(12): 113524 [PMID: 41480226 DOI: 10.4251/wjgo.v17.i12.113524]
URL:	https://www.wjgnet.com/1948-5204/full/v17/i12/113524.htm

(29) (32) (0) (0) (0) (1) (649) (4)

Number	Citing Articles
1	Zi-Wei Wang, Li Jia, Ling-Ke Qu, Guo-Hua Gong. Inhibiting exosomal miR-191 can induce ferroptosis in macrophages, thereby delaying the progression of colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(5): 116881 doi: 10.4251/wjgo.v18.i5.116881 Abstract(63) \| Core Tip(62) \| Full Article(HTML)(172) \| Full Article (PDF)-484K(30) \| Full Article with Cover (PDF)-807K(15) \| Full Article (XML)-62K(16) \| Audio-539K(3) \| Peer-Review Report-157K(17) \| Answering Reviewers-164K(18) \| Times Cited (0) \| Total Visits (295) \| Open
2	Amr Ahmed El-Arabey. Exosomal miR-191 activates the NF-κB pathway to drive M2 macrophages polarization in colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(3) doi: 10.4251/wjgo.v18.i3.117110 Abstract(0) \| Core Tip(0) \| Full Article(HTML)(0) \| Times Cited (0) \| Total Visits (0) \| Open
3	Amr Ahmed El-Arabey. Letter to the Editor: Exosomal miR-191 activates the NF-κB pathway to drive M2 macrophages polarization in colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(6): 117110 doi: 10.4251/wjgo.v18.i6.117110 Abstract(38) \| Core Tip(77) \| Full Article(HTML)(118) \| Full Article (PDF)-3707K(24) \| Full Article with Cover (PDF)-4054K(8) \| Full Article (XML)-40K(17) \| Audio-1056K(3) \| Peer-Review Report-236K(15) \| Answering Reviewers-147K(15) \| Supplementary Material-422K(14) \| Times Cited (0) \| Total Visits (196) \| Open
4	Yihang Shen, Baojun Ju. Research progress on the mechanism, diagnosis, and treatment of exosomal miRNA in chronic prostatitis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1888573

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.